Ledger.Open graph →
SEC Form D · filed April 4, 2025

NEURONA THERAPEUTICS, INC

Offering
$101.7M
Sold
$101.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Leo R. Guthart · South San Francisco, CADirectorJames Stutz · South San Francisco, CAExecRay Kelleher · South San Francisco, CADirectorBrad Margus · South San Francisco, CADirectorTim Kutzkey · South San Francisco, CADirectorErica Whittaker · South San Francisco, CADirectorCory Nicholas · South San Francisco, CAExec · Director · PromoterPeter Svennilson · South San Francisco, CADirectorMichael Burwell · New York, NYDirectorWilliam R. Woo · New York, NYDirectorJames Stutz · South San Francisco, CAExecMicah Kinsler · Suite 101, AZDirectorRay Kelleher · South San Francisco, CADirectorAlan Badey · New York, NYExec · Director · PromoterCatherine Sohn · South San Francisco, CADirectorAlger A. St-Jean · Toronto, Ontario, CanadaDirectorDhivya Venkat · London, United KingdomDirectorBobby Ocampo · Solana Beach, CADirectorMinyoung Sohn · Denver, COExec · Director · PromoterMoshe Lifschitz · Englewood, NJDirectorJeffrey F. O'Donnell Sr · Malvern, PADirectorJohnathan L. Manning · Savannah, GAExecPeter Svennilson · Encinitas, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗